作者
Wei Gao,Shiyi Gan,Mengting Zhang,Asuka Inoue,Mengting Xie,Ming He,Huan Zhu,Shanshan Guo,Chen Qiu,Di Chang,Jinling Yu,Zhao Deng,Fang Ye,Shiliang Li,Jian Zhang,Zhenjiang Zhao,Mengzhu Xue,Bernard Ofosuhene,Yufang Xu,Honghuang Lin,Xuhong Qian,Li Zhu,Yang Du,Huangjuan Li
摘要
Abstract S1PR4 is one of five subtypes of sphingosine 1-phosphate receptors (S1PRs) that regulate immune cell functioning, with functional distinctions to other subtypes. S1PR1-targeted modulators caused serious cardiac and vascular adverse effects because S1PR1 was expressed throughout the whole body. Since S1PR4 was only expressed in lung and lymphoid cells, S1PR4-targeted modulators might not trigger these side effects. However, the development of S1PR4-specific agonists is greatly hindered because of the lack of activated S1PR4 structure. Here, we resolved cryo-EM structures of activated S1PR4 and revealed the structural mechanism of ligand recognition, receptor activation, and Gα i coupling. Our results offered structural templates for the development of selective S1PR4 agonists with improved safety profiles.